Edition:
United Kingdom

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

304.40GBp
16 Aug 2019
Change (% chg)

1.10 (+0.36%)
Prev Close
303.30
Open
307.70
Day's High
307.70
Day's Low
297.70
Volume
838,690
Avg. Vol
1,029,082
52-wk High
506.80
52-wk Low
288.30

Latest Key Developments (Source: Significant Developments)

Mediclinic Says Chairman Edwin Hertzog To Retire
Wednesday, 24 Jul 2019 

July 24 (Reuters) - Mediclinic International PLC ::MEDICLINIC - EDWIN HERTZOG, 69, HAS INDICATED HIS INTENTION TO RETIRE AS CHAIRMAN AT CONCLUSION OF ANNUAL GENERAL MEETING IN JULY 2020.MEDICLINIC INTERNATIONAL PLC - SEARCH FOR HERTZOG'S SUCCESSOR AS CHAIRMAN WILL BE INITIATED IN DUE COURSE.  Full Article

Mediclinic's Swiss Hospital Operators Have Been Affected By Outpatient Tariff Reductions
Thursday, 23 May 2019 

May 23 (Reuters) - Mediclinic International PLC ::MEDICLINIC INTNL PLC - FINAL RESULTS.MEDICLINIC INTERNATIONAL PLC - GROUP ADJUSTED FULL-YEAR FINANCIAL RESULTS IN LINE WITH MARKET EXPECTATIONS.MEDICLINIC INTERNATIONAL PLC - PROPOSED FINAL DIVIDEND MAINTAINED AT 4.70 PENCE PER SHARE.MEDICLINIC INTERNATIONAL PLC - CURRENT TRADING IN LINE WITH EXPECTATIONS; GUIDANCE REMAINS UNCHANGED.MEDICLINIC INTERNATIONAL PLC - FY REVENUE UP 2% TO GBP2 932M; UP 4% IN CONSTANT CURRENCY TERMS.MEDICLINIC INTERNATIONAL PLC - FY ADJUSTED EBITDA OF GBP493M DOWN 4%; DOWN 2% IN CONSTANT CURRENCY TERMS.MEDICLINIC INTERNATIONAL PLC - FY ADJUSTED OPERATING PROFIT OF GBP330M DOWN 11%.MEDICLINIC - OVER LAST 18 MONTHS, SWISS HOSPITAL OPERATORS AFFECTED BY IMPLEMENTED REGULATORY CHANGES RELATED TO OUTPATIENT TARIFF REDUCTIONS.MEDICLINIC INTERNATIONAL PLC - TOOK ACTIONS TO IMPROVE HIRSLANDEN'S PERFORMANCE.MEDICLINIC INTERNATIONAL PLC - HIRSLANDEN DELIVERING A 16% EBITDA MARGIN FOR FULL YEAR, IN LINE WITH GUIDANCE..MEDICLINIC INTERNATIONAL PLC - DISAPPOINTING PERFORMANCE AT HIRSLANDEN WHERE CHANGES HAVE IMPACTED TARIFF ENVIRONMENT AND INPATIENT INSURANCE MIX.  Full Article

Mediclinic International Says 2019 Results Were In Line With Market Expectations
Wednesday, 17 Apr 2019 

April 17 (Reuters) - Mediclinic International PLC ::2019 FULL YEAR TRADING UPDATE.GROUP RESULTS FOR 2019 FINANCIAL YEAR WERE IN LINE WITH MARKET EXPECTATIONS.IN SWITZERLAND, HIRSLANDEN'S PERFORMANCE IN SECOND HALF OF YEAR WAS AS GUIDED, RESULTING IN A FULL YEAR EBITDA MARGIN OF AROUND 16%.IN FINANCIAL YEAR ENDING 31 MARCH 2020 HIRSLANDEN EXPECTS MODEST REVENUE GROWTH FROM AN INCREASE IN AVERAGE BED CAPACITY FOR YEAR.IN CURRENT REGULATORY ENVIRONMENT, HIRSLANDEN TO BE IMPACTED BY FURTHER 9 MONTHS' EFFECT IN FY20 FROM NATIONAL OUTMIGRATION CARE PROGRAMME.HIRSLANDEN EBITDA MARGIN FOR FY19 WAS AROUND 16.0% (FY18: 18.3%).HIRSLANDEN FY20 EBITDA MARGIN EXPECTED TO BE AROUND 15%.IN FY20, MEDICLINIC SOUTHERN AFRICA EXPECTS VOLUME GROWTH OF AROUND 1%.IN MEDICLINIC MIDDLE EAST, FY19 REVENUE WAS UP AROUND 7.0% (FY18: AED3 050M).IN FY20, MIDDLE EAST DIVISION IS EXPECTED TO DELIVER REVENUE GROWTH OF AROUND 10%.AT GROUP LEVEL, IN CONSTANT CURRENCY, FY19 REVENUE WAS UP AROUND 3.5% AND EBITDA WAS DOWN AROUND 1.5%.ON A REPORTED BASIS, FY19 REVENUE WAS UP AROUND 2.0% (FY18: GBP2 870M) AND EBITDA WAS DOWN AROUND 3.5% (FY18: GBP515M).  Full Article

S.Africa's Competition Tribunal Stops Mediclinic Southern Africa- Matlosana Deal
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - S.AFRICA'S COMPETITION TRIBUNAL::PROHIBITED MERGER BETWEEN MEDICLINIC SOUTHERN AFRICA & MATLOSANA MEDICAL HEALTH SERVICES IN NORTH WEST PROVINCE.  Full Article

Mpilo Investment Holdings 2 (Rf) (Pty) Ltd Dissolves Stake In Mediclinic International Plc - Filing
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - Mediclinic International PLC ::MPILO INVESTMENT HOLDINGS 2 (RF) (PTY) LTD DISSOLVES STAKE IN MEDICLINIC INTERNATIONAL PLC - FILING.  Full Article

Mediclinic Says Forecast For Middle East Division Unchanged
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Mediclinic International PLC ::GUIDANCE FOR MEDICLINIC MIDDLE EAST REMAINS UNCHANGED.MEDICLINIC MIDDLE EAST EXPECTS TO DELIVER FY19 REVENUE GROWTH IN HIGH SINGLE-DIGIT PERCENTAGE RANGE.  Full Article

Mediclinic Experiences Customary Seasonality In Switzerland, Middle East In H1 Trading
Wednesday, 17 Oct 2018 

Oct 17 (Reuters) - Mediclinic International PLC ::MEDICLINIC INTERNATIONAL - IN MIDDLE EAST, 182-BED MEDICLINIC PARKVIEW HOSPITAL IN DUBAI OPENED IN SEPTEMBER ON TIME AND IN BUDGET.MEDICLINIC INTERNATIONAL PLC - RECENTLY COMPLETED BUILD OF OUR FOURTH DAY CLINIC AT MEDICLINIC NEWCASTLE WHICH IS EXPECTED TO OPEN SHORTLY.MEDICLINIC INTERNATIONAL PLC - CONTINUE TO PROGRESS WITH HIRSLANDEN 2020 STRATEGIC PROGRAMME.MEDICLINIC INTERNATIONAL PLC - TRADING IN FIRST HALF OF YEAR EXPERIENCED CUSTOMARY SEASONALITY IN SWITZERLAND AND MIDDLE EAST.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, WE DELIVERED A GRADUAL IMPROVEMENT IN REVENUE AND MARGIN EXPANSION IN H1.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, BUSINESS CONTINUES TO ADAPT TO RECENT REGULATORY CHANGES IN OUTPATIENT ENVIRONMENT IN H1.MEDICLINIC INTERNATIONAL PLC - IN SOUTHERN AFRICA, H1 MARGINS WERE MAINTAINED ON LOWER VOLUMES DUE TO WEAKNESS IN Q2.MEDICLINIC INTERNATIONAL PLC - FOR FULL YEAR, PERFORMANCE IN SOUTHERN AFRICA REMAINS IN LINE WITH GUIDANCE.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, FULL YEAR EBITDA DELIVERY REMAINS ON TRACK WITH REVENUE GROWTH LOWER THAN PREVIOUSLY EXPECTED.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, WE NOW EXPECT TO DELIVER MODEST REVENUE GROWTH IN FULL YEAR.MEDICLINIC INTERNATIONAL PLC - AT GROUP LEVEL, IN CONSTANT CURRENCY, 1H19 REVENUE WAS UP 2% AND ADJUSTED EBITDA WAS DOWN AROUND 4%.  Full Article

Mediclinic International Says Guidance Remains Unchanged With Trading In Line With Expectations
Thursday, 28 Jun 2018 

June 28 (Reuters) - Mediclinic International PLC ::GUIDANCE REMAINS UNCHANGED WITH TRADING IN LINE WITH EXPECTATIONS.  Full Article

Mediclinic International Says CEO To Continue As A Non-Executive Director
Thursday, 24 May 2018 

May 24 (Reuters) - Mediclinic International PLC ::CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.RONNIE VAN DER MERWE WILL SUCCEED MEINTJES AS CHIEF EXECUTIVE DIRECTOR ON 1 JUNE 2018.  Full Article

Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Mediclinic International Plc ::‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​.MERWE ‍TO SUCCEED DANIE MEINTJES AS CEO OF COMPANY ON A DATE TO BE MUTUALLY AGREED, BUT NOT LATER THAN 1 AUGUST 2018​.  Full Article

UPDATE 1-S Africa puts initial universal healthcare cost at $17 bln

PRETORIA, Aug 8 South Africa published its draft National Health Insurance (NHI) bill on Thursday, with one senior official estimating universal healthcare for millions of poorer citizens would cost about 256 billion rand ($16.89 billion) to implement by 2022.